Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium

Cell and Tissue Banking

Volumn 15, Issue 4, 2014, Pages 513-521

  Chen, Gecai ^a   Yue, Aihuan ^b   Ruan, Zhongbao ^a   Yin, Yigang ^a   Wang, Ruzhu ^a   Ren, Yin ^a   Zhu, Li ^a  

^a Department of Cardiology Taizhou Renmin Hospital   (China)

^b Yangtze River Pharmaceutical Group Co   (China)

Author keywords

Biological stability; Cell apoptosis; Cell cycle; Cell differentiation; Mesenchymal stem cell (MSC)

Indexed keywords

CULTURE MEDIUM;

APOPTOSIS; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHARMACOLOGY; PROCEDURES; TIME; UMBILICAL CORD;

APOPTOSIS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TIME FACTORS; UMBILICAL CORD;

EID: 84911973972     PISSN: 13899333     EISSN: 15736814     Source Type: Journal    
DOI: 10.1007/s10561-014-9420-6     Document Type: Article

References (22)

1. Ahrari I, Purhabibi Zarandi N, Khosravi Maharlooei M et al (2013) Adipose tissue derived multipotent mesenchymal stromal cells can be isolated using serum-free media. Iran Red Crescent Med J 15(4):324–329
2. Bobis S, Jarocha D, Majka M (2006) Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44:215–230
3. Castrechini NM, Murthi P, Gude NM et al (2010) Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche. Placenta 31:203–212
4. Corotchi MC, Popa MA, Remes A, Sima LE, Gussi I, Lupu Plesu M (2013) Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells. Stem Cell Res Ther 4:81
5. Ding DC, Chou HL, Hung WT, Liu HW, Chu TY (2013) Human adipose-derived stem cells cultured in keratinocyte serum free medium: donor’s age does not affect the proliferation and differentiation capacities. J Biomed Sci 20(1):59
6. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
7. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267–274
8. Jin ES, Min J, Jeon SR, Choi KH, Jeong JH (2013) Analysis of molecular expression in adipose tissue-derived mesenchymal stem cells: prospects for use in the treatment of intervertebral disc degeneration. J Korean Neurosurg Soc 53:207–212
9. Passeri S, Nocchi F, Lamanna R et al (2009) Isolation and expansion of equine umbilical cord-derived matrix cells (EUCMCs). Cell Biol Int 33:100–105
10. Patrikoski Mimmi, Juntunen Miia, Boucher Shayne et al (2013) Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells. Stem Cell Res Ther 4(2):27
11. Redaelli S, Bentivegna A, Foudah D et al (2012) From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3:47
12. Sensebe L (2008) Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18:S3–S10
13. Seshareddy K, Troyer D, Weiss ML (2008) Method to isolate mesenchymal-like cells from Wharton’s Jelly of umbilical cord. Methods Cell Biol 86:101–119
14. Shaffer L, Slovak ML, Campbell LJ (2009) ISCN 2009, an international system for human cytogenetic nomenclature
15. Shin S, Sun Y, Liu Y et al (2007) Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells 25:1298–1306
16. Shujia J, Haider HK, Idris NM, Lu G, Ashraf M (2008) Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res 77:525–533
17. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462–471
18. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484–1490
19. Trivanovic D, Kocic J, Mojsilovic S et al (2013) Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton’s jelly. Srp Arh Celok Lek 141:178–186
20. Yang LM, Bi LQ, Jiang WH (2008) Biological characterization of human umbilical cord mesenchymal stem cells following tissue mass cell culture. J Clin Rehabil Tissue Eng Res 12:9221–9225
21. Zeng Q, Shi MA, Qian P (2008) Efficient derivation of mesenchymal stem cells and neural precursor cells from human embryonic stem cells through teratoma formation. Prog Biochem Biophys 35:1417–1424
22. Zhou P, Li D, Chen GH, Wang Y (2013) Serum-free culture of umbilical cord mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(5):1256–1260